ecrin-mdr-crcClinical2016diabetes, non-alcoholic lipid liver disease / non-alcoholicity fat hepatitis, inflammatory bowel disease (ulcerative colitis, Crohn’s disease), irritable bowel disease, neuroimmune disease, lung cancer, esophageal cancer, gastric cancer, colorectal cancerDiabetes, Non-alcoholic Lipid Liver Disease / Non-alcoholicity Fat Hepatitis, Inflammatory Bowel Disease (ulcerative Colitis, Crohn’s Disease), Irritable Bowel Disease, Neuroimmune Disease, Lung Cancer, Esophageal Cancer, Gastric Cancer, Colorectal CancerObservationalhttps://newmdr.ecrin.org/Study/2634775Japan2ECRIN MDRRecruitingfalseEnterobacterial analysis for the precise medical care (precision medicine) for diabetes, non-alcoholic lipid liver disease / non-alcoholicity fat hepatitis, inflammatory bowel disease, and irritable bowel syndrome.Primary outcome(s): Tendency of the enterobacterial flora of each disease compared to healthy control.2016-02-152634775JPRN-UMIN000019486